home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Tonix Pharmaceuticals Holding Corp. - Common Stock (NQ:TNXP)

16.14 -0.76 (-4.50%)

Streaming Delayed Price Updated: 12:06 PM EST, Jan 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tonix Pharmaceuticals Holding Corp. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Why Tonix Pharmaceuticals Stock (TNXP) Is Getting Obliterated ↗

March 28, 2024

Tonix Pharmaceuticals shares are trading lower by 22.3% Thursday afternoon. The company announced the pricing of a $4.4 million registered direct offering.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 28, 2024

Via Benzinga

3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million ↗

March 24, 2024

If you want the chance at possible absurd returns, then consider gambling on these stocks to turn $1,000 into $1 million.

Via InvestorPlace

New to the Street TV Series on Bloomberg and Fox Business, Innovative Companies Spotlighted: ACXP, TNXP, PETV, SWISF, GEVI, CLNV

February 29, 2024

Via AB Newswire

New Drug Study Shows Improving Sleep Quality Can Relieve Fibromyalgia Pain

February 26, 2024

Via ACCESSWIRE

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Risk of Addiction

February 15, 2024

Via ACCESSWIRE

Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ:TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL

December 14, 2023

Via ACCESSWIRE

New Hope for Long COVID Sufferers

October 25, 2023

Via ACCESSWIRE

3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond ↗

February 25, 2024

When you want to light your afterburners, these ideas will do the trick.

Via InvestorPlace

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

February 15, 2024

EQNX::TICKER_START (NASDAQ:TNXP),(NYSE:PFE),(NYSE:LLY),(NYSE:ABBV),(NYSE:MRK) EQNX::TICKER_END

Via FinancialNewsMedia

Leading The Charge: Tonix Pharmaceuticals And The Future Of CNS Therapeutics

February 13, 2024

Via Get News

Tonix Drug Shown To Relieve Pain in Fibromyalgia Without Getting Patients Addicted In Phase 3 Trial ↗

February 09, 2024

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The...

Via Benzinga

Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032

February 15, 2024

From FN Media Group LLC

Via GlobeNewswire

New Hope For Fibromyalgia Patients: Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval

February 01, 2024

Via ACCESSWIRE

New Hope For Fibromyalgia Patients? Tonix Details Results Of Second Successful Phase 3 Trial And Plans To File For FDA Approval ↗

January 30, 2024

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and Tonix Pharmaceuticals Holding Corp, a financial partner of Benzinga. The...

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Shares Are Plummeting ↗

December 20, 2023

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 30.8% to $0.41 during Wednesday's session after the company announced it is securing up to $144 million in funding through...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 20, 2023

Via Benzinga

Hope On The Horizon: Tonix Pharmaceuticals (NASDAQ: TNXP) Could Be On the Cusp of Changing Fibromyalgia Treatment Options With TNX-102 SL ↗

December 14, 2023

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 07, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 17, 2023

Via Benzinga

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

November 01, 2023

Gainers

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Stock Is Falling Sharply Today ↗

November 01, 2023

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 17% to $0.49 Wednesday morning. The company late Tuesday announced the topline results of a Phase 2 study for TNX-601 ER, a...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 01, 2023

Via Benzinga

Why Plus Therapeutics Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket ↗

November 01, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

November 01, 2023

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers investors will want to keep track of today!

Via InvestorPlace

New Hope For Long COVID Sufferers ↗

October 25, 2023

Tonix’s Therapeutic Development Program is Aligned with National Goal for Better Solutions TONIX: Effect of TNX-102 SL on Fatigue in Proof-of-Concept Phase 2 Study Sets Stage for Developing...

Via Benzinga

Why SeaStar Medical Holding Shares Are Trading Higher By Around 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

September 29, 2023

Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 29, 2023

Via Benzinga

Why Tonix Pharmaceuticals (TNXP) Shares Are Getting Obliterated ↗

September 29, 2023

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 23.3% to $0.54 Friday morning after the company announced the pricing of a $4.5 million public offering of

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com